Dropbox Inc vs IDEXX Laboratories, Inc. — how do they compare? Dropbox Inc trades at $33.58 (market cap $7.41B), while IDEXX Laboratories, Inc. trades at $572.54 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 6.2× Dropbox Inc's market cap, and Dropbox Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| DBX | IDXX | |
|---|---|---|
Market Cap | $7.41B | $46.22B |
Sector | Technology | Health |
52-Week High | $35.00 | $766.68 |
52-Week Low | $22.06 | $526.44 |
Enterprise Value | $10.27B | $47.12B |
Signals from Pluang's Aura AI — not financial advice
Dropbox (DBX) trades at $33.68, down 2.63% on the day, yet maintains a bullish technical trend with consistent earnings beats in recent quarters. The company reported Q2 2026 EPS of $0.75, exceeding expectations of $0.74, driven by core file-sync-and-share growth and AI expansion. Despite a negative shareholder equity position, operating cash flow remains strong at $952 million for 2025, supporting ongoing business investments.
The outlook is cautiously optimistic, with raised 2026 guidance signaling management confidence, but high debt levels and competitive pressures in cloud storage pose risks. Analyst sentiment is mixed, with 37.5% recommending buy, highlighting potential upside if execution continues, though investors should weigh valuation against balance sheet concerns.
IDEXX Laboratories (IDXX) trades at $595.76, up 1.55% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $4.27 versus $3.94 expected, driven by 9% organic revenue growth. The company raised full-year EPS guidance to $14.69–14.94, reflecting robust demand in companion animal diagnostics. Valuation ratios remain elevated with a P/E of 41.23, supported by high profitability margins including a net income margin of 25.03% and ROE of 74.21%.
Outlook is positive given consistent earnings beats, international expansion, and product innovation, but risks include premium valuation sensitivity and competitive pressures. The consensus price target of $683.33 implies 14.7% upside, with 57% of analysts rating it Buy. Investors should weigh growth durability against high multiples.
Trailing returns across standard periods
Latest headlines on both assets
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →